[Anti-angina Effectiveness of Isosorbide Dinitrate in an Acute Trial and Following Continuous 4-week Therapy with 40 Mg 6 Times a Day]

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1985 May 15

PMID 3925217

Citations 1

Authors

W Schneider

A Wietschoreck

W D Bussmann

M Kaltenbach

Affiliations

Soon will be listed here.

Abstract

Ten patients with angiographically proven coronary heart disease, stable exercise-induced angina pectoris, and reproducible ST-segment depression were treated with isosorbide dinitrate (ISDN) tablets in daily doses of 240 mg (6 X 40 mg) and placebo (PL) for 28 days each on the basis of a randomized double-blind protocol with intraindividual cross-over. ISDN treatment resulted in a sustained reduction of anginal attacks with a weekly mean rate ranging from 1.4 (3rd week) to 3.9 (4th week) as compared to 10.2 (2nd week) to 11.7 (4th week) during placebo treatment (P less than 0.001). Ischemic response during stress testing (sum of ST-segment depressions) was significantly improved during ISDN treatment as compared to placebo. Day 1: 56% (P less than 0.01); day 7: 30% (P less than 0.01); day 28: 49% (P less than 0.001). Heart rate and arterial blood pressure in the upright position were different between ISDN and placebo on day 1 and day 7 of the treatment phases (P less than 0.02), but not on day 28. Nitrate responsiveness with regard to blood pressure and heart rate was restored after a drug-free interval of 2 days. The plasma concentrations for ISDN and the mononitrate metabolites exhibited a constant ratio during the treatment period. Thus, therapy with 6 X 40 mg ISDN per day resulted in a sustained reduction of anginal attacks and preserved improvement of ischemic ST-segment depression during exercise in upright position.

Citing Articles

Nitrate tolerance. A review of the evidence.

Flaherty J Drugs. 1989; 37(4):523-50.

PMID: 2661197 DOI: 10.2165/00003495-198937040-00006.

References

Silber S, Krause K, Garner C, Theisen K, JAHRMARKER H . Anti-ischemic effects of an 80-mg tablet of isosorbide dinitrate in sustained-release form before and after 2 weeks treatment with 80 mg once daily or twice daily. Z Kardiol. 1983; 72 Suppl 3:211-7. View

Franciosa J, Leddy C, Schwartz D . Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure. Z Kardiol. 1983; 72 Suppl 3:168-72. View

Leier C, Huss P, Magorien R, Unverferth D . Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983; 67(4):817-22. DOI: 10.1161/01.cir.67.4.817. View

Tauchert M, Jansen W, Osterspey A, Fuchs M, Hombach V, Hilger H . Dose dependence of tolerance during treatment with mononitrates. Z Kardiol. 1983; 72 Suppl 3:218-28. View

NEEDLEMAN P, Johnson Jr E . Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973; 184(3):709-15. View

Schneider W, Bussmann W, Stahl B, Kaltenbach M . Dose-response relation of antianginal activity of isosorbide dinitrate. Am J Cardiol. 1984; 53(6):700-5. DOI: 10.1016/0002-9149(84)90389-8. View

BLASINI R, Brugmann U, Mannes A, Froer K, Hall D, Rudolph W . [Disparate efficacy of isosorbide dinitrate, in sustained-release form, during acute and chronic administration (author's transl)]. Herz. 1980; 5(5):298-305. View

Kenedi P, Giebeler B . Antianginal efficacy of long-term nitrate therapy. Z Kardiol. 1983; 72 Suppl 3:233-8. View

Thadani U, Fung H, Darke A, PARKER J . Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982; 49(2):411-9. DOI: 10.1016/0002-9149(82)90518-5. View

10.

Franciosa J, Cohn J . Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol. 1980; 45(3):648-54. DOI: 10.1016/s0002-9149(80)80018-x. View

11.

Kaltenbach M, Tiedemann I, Schellhorn W . [The effect of five different long-acting nitroglycerine derivatives on angina pectoris]. Dtsch Med Wochenschr. 1972; 97(40):1479-84. DOI: 10.1055/s-0028-1107586. View

12.

Lee G, Mason D, De Maria A . Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing. Am J Cardiol. 1978; 41(1):82-7. DOI: 10.1016/0002-9149(78)90136-4. View

13.

ROSENKRANZ K, Drews A . [ON A MODIFIED LEAD METHOD FOR REGISTERING THORACIC WALL ELECTROCARDIOGRAMS DURING MEASURED PHYSICAL EXERTION]. Z Kreislaufforsch. 1964; 53:615-8. View

14.

Jansen W, Tauchert M, Osterspey A, Hombach V, Fuchs M, Hilger H . Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine. Z Kardiol. 1983; 72 Suppl 3:203-10. View

15.

Becker H, Walden G, Kaltenbach M . [Is there a tachyphylaxis or drug resistance in the treatment of angina pectoris using nitro-bodies]. Verh Dtsch Ges Inn Med. 1976; 82 Pt 2:1208-10. View

16.

Kaltenbach M, Klepzig H, TSCHIRDEWAHN B . [THE CLIMBING STEP, A SIMPLE PROCEDURE FOR EXACTLY MEASURABLE AND REPRODUCIABLE EXERCISE TESTS]. Med Klin. 1964; 59:248-54. View

17.

Danahy D, Burwell D, Aronow W, Prakash R . Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate. Circulation. 1977; 55(2):381-7. DOI: 10.1161/01.cir.55.2.381. View

18.

Rudolph W, BLASINI R, Reiniger G, Brugmann U . Tolerance development during isosorbide dinitrate treatment: can it be circumvented?. Z Kardiol. 1983; 72 Suppl 3:195-8. View

19.

Rosseel M, Bogaert M . GLC determination of nitroglycerin and isosorbide dinitrate in human plasma. J Pharm Sci. 1973; 62(5):754-8. DOI: 10.1002/jps.2600620510. View

20.

Schneider W, Stahl B, Kaltenbach M, Bussmann W . [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)]. Dtsch Med Wochenschr. 1982; 107(20):771-6. DOI: 10.1055/s-2008-1070018. View